Effect of triptolide on focal adhesion kinase and survival in MCF-7 breast cancer cells
Related Experiment Video
Updated: May 30, 2026

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration
Published on: June 9, 2023
Bee-Jen Tan1, Bee-Huey Tan, Gigi N C Chiu
1Department of Pharmacy, Faculty of Science, National University of Singapore, Singapore 117543, Singapore.
Abstract:
Triptolide, a diterpene from Tripterygium wilfordii, has been shown to have potent anticancer activity, exerting its effects through multiple molecular targets and signaling pathways. Yet, its effect on focal adhesion kinase (FAK), a non-receptor tyrosine kinase overexpressed in breast cancer that regulates cellular adhesion and survival, has not been reported. The current study is the first to report on the effect of triptolide on FAK expression, cell adhesion and survival using MCF-7 breast cancer cells. Triptolide significantly reduced MCF-7 anchorage-independent growth in a concentration-dependent manner. Cell rounding and detachment from culture plates were observed as early as 8 h, with significant cell detachment observed after 24 h of triptolide treatment. The adhesion potential of triptolide-treated MCF-7 cells to Matrigel was also compromised. Triptolide induced concentration- and time-dependent cleavage of FAK and PARP, which was dependent on caspase activation. The pan-caspase inhibitor, zVAD-fmk, was the only inhibitor that could significantly reduce FAK and PARP cleavage and cell detachment. However, the presence of zVAD-fmk failed to significantly reverse triptolide-induced cell death. Finally, triptolide-induced FAK cleavage was specific to MCF-7 cells, as no cleaved FAK was observed in MDA-MB-231 cells. In conclusion, our data present the first evidence of triptolide-mediated induction of FAK cleavage that correlates with cell detachment and loss of adhesion potential to the extracellular matrix.
Insights
Triptolide, an anticancer compound, induces focal adhesion kinase (FAK) cleavage in breast cancer cells, leading to cell detachment and reduced survival. This effect is caspase-dependent but does not prevent cell death.
Area of Science:
- Molecular Biology
- Cancer Research
- Pharmacology
Background:
- Triptolide exhibits potent anticancer activity via multiple molecular targets.
- Focal adhesion kinase (FAK) is a key regulator of cell adhesion and survival, and is overexpressed in breast cancer.
- The effect of triptolide on FAK in breast cancer cells was previously unreported.
Purpose of the Study:
- To investigate the effect of triptolide on FAK expression, cell adhesion, and survival in MCF-7 breast cancer cells.
- To elucidate the molecular mechanisms underlying triptolide's action on FAK and cell viability.
Main Methods:
- Treatment of MCF-7 cells with varying concentrations of triptolide.
- Assessment of anchorage-independent growth, cell adhesion to Matrigel, and cell detachment.
- Analysis of FAK and PARP cleavage using Western blotting.
- Evaluation of caspase activation and inhibition using a pan-caspase inhibitor (zVAD-fmk).
Main Results:
- Triptolide significantly reduced anchorage-independent growth and induced cell rounding and detachment in a concentration- and time-dependent manner.
- Triptolide treatment compromised MCF-7 cell adhesion to Matrigel.
- Triptolide induced concentration- and time-dependent cleavage of FAK and PARP, dependent on caspase activation.
- While a caspase inhibitor reduced FAK/PARP cleavage and cell detachment, it did not prevent triptolide-induced cell death.
- Triptolide-induced FAK cleavage was specific to MCF-7 cells.
Conclusions:
- Triptolide induces FAK cleavage in MCF-7 breast cancer cells, correlating with cell detachment and reduced adhesion.
- Caspase activation is essential for triptolide-induced FAK cleavage and cell detachment, but not for triptolide-mediated cell death.
- These findings highlight a novel mechanism of triptolide action involving FAK cleavage in breast cancer.
More Related Videos
13:38Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Intracellular Signaling Affects Focal Adhesions
Some...